<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Classical Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/L) presenting L3 <z:mp ids='MP_0000002'>morphology</z:mp> is found in 1% of <z:e sem="disease" ids="C0023452" disease_type="Neoplastic Process" abbrv="">childhood ALL</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, it has been described that secondary abnormalities could influence the prognosis of these patients </plain></SENT>
<SENT sid="2" pm="."><plain>However, little information is available on these cytogenetic abnormalities and their prognostic importance in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/L </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we report four new childhood <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/L cases associated with duplication within 1q or 13q, which exhibited a very unfavorable therapeutic response </plain></SENT>
<SENT sid="4" pm="."><plain>We performed both classical and molecular cytogenetic analysis by multicolor chromosome banding of the secondary abnormalities involving the long arms of chromosome 1 or 13 </plain></SENT>
<SENT sid="5" pm="."><plain>These patients were previously treated with BFM-90 protocol </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of them died during or after the initial treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Here, for the first time, the exact breakpoints of the derivative chromosomes involved were determined at the cytogenetic level as 1q21 and 13q33 each </plain></SENT>
</text></document>